• CPTI Programs
  • CPTAC
  • Advanced Proteomic Platforms and Computational Sciences
  • Proteomic Reagents and Resource Core
• Mouse Proteomics Initiative

CPTI Programs

In order to reach its overall goal of advancing the field of clinical cancer proteomics, the Clinical Proteomic Technologies for Cancer is comprised of two interrelated Initiatives:

The Clinical Proteomic Technologies Initiative (CPTI), which includes the following three programs:

1. Clinical Proteomic Technology Assessment for Cancer (CPTAC)
   CPTAC is a multidisciplinary team network of leading proteomics researchers and institutions that are conducting rigorous technology assessment and optimization; developing standard protocols and clinical reference sets; and evaluating methods to ensure data reproducibility.
2. Advanced Proteomic Platforms and Computational Sciences
   The Advanced Proteomic Platforms and Computational Sciences is a comprehensive program that supports individual investigator-driven efforts focused on the development of innovative new tools, reagents, and the enabling of technologies for protein/peptide measurement, such as algorithm development and computational methods to interrogate emerging pre-processed data sets.
3. Proteomic Reagents and Resource Core
   The Proteomic Reagents and Resource Core will serve the investigator community as a central public source for proteomics research and clinical reagents and the information for their use.

And the

Mouse Proteomic Technologies Initiative , which takes advantage of the opportunities to optimize procedures for profiling major human cancers offered by mouse models of human cancer, and provides reagents and computational resources for the entire scientific community.